Sanchay Finvest (511563)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Piotroski F-Score of 6/9 suggests some recent financial-health indicators are positive.
• Book value is positive at ₹11.05 per share, providing some residual asset backing.
• The price has fallen well below the 52-week high of ₹64.95, reducing some prior speculative froth.

Concerns

• Return on equity of -29.15% indicates significant shareholder value destruction.
• The stock trades at 3.12 times book value despite negligible earnings, leaving no margin of safety.
• Sales and profit growth are zero, and the latest quarter shows no real operating activity.
• No dividend and unavailable promoter holding data raise income and governance concerns.

AI Analysis

Let me apply the first test: can I understand this business and does it earn attractive returns on capital? Sanchay Finvest has a P/E of 0.00, which simply tells me current earnings are negligible or zero, so my usual valuation tools fail. The return on equity is -29.15%, meaning the company is destroying roughly a quarter of its book value every year. ROCE is -0.94%, so operations are not even covering the cost of the capital employed. Sales growth and profit growth are both 0.00%, and the latest quarter shows sales and net profit of ₹-0 Cr, which rounds to no real business activity. This is not a growing franchise. At ₹34.47, the market cap is just ₹11 Cr, and I am being asked to pay 3.12 times a book value of ₹11.05 for a business that is losing money. That offers no margin of safety. The 52-week range of ₹24.00 to ₹64.95 tells me this is a speculative stock, not an investment. The Piotroski F-Score of 6/9 is a moderate sign, but it cannot rescue such poor economics. There is zero dividend, so I receive no income while waiting, and promoter holding data is unavailable, which adds a transparency worry. Graham would say price and value are not the same thing; here every fundamental indicator points to weak business quality, negative profitability, and an expensive valuation relative to book. I cannot call this a Stalwart or a Grower. At best, it is a speculative Turnaround, and only if management can prove a path to real positive earnings and honest capital allocation. Until then, I pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer